AstraZeneca’s CEO, a French-born Australian running an Anglo-Swedish company, is betting $50 billion on a strategy of making the US its largest market — while also pouring $15 billion into China. Each ...

Add Yahoo as a preferred source to see more of our stories on Google. A view of a helmet with the AstraZeneca logo next to a bust of former U.S. President Abraham Lincoln on the day of an announcement ...

AstraZeneca (AZN) is shifting its focus to the US, calling itself an "American company" on Tuesday as it ramps up manufacturing and proposes price cuts for the US market. CEO Pascal Soriot told ...

The boss of drug giant AstraZeneca has warned that the UK is deterring investment from the pharma industry. Chief executive Pascal Soriot said Britain should be trying to attract cash from the sector ...

AstraZeneca CEO Pascal Soriot on Tuesday reiterated the pharmaceutical firm's commitment to the U.S. market amid reports that he is considering shifting its listing stateside. Stream Los Angeles News ...

AstraZeneca is giving Pascal Soriot a pay raise as the longtime CEO weathered a year of “significant geopolitical uncertainty” to advance the British pharma toward an ambitious 2030 goal. For 2025, ...

AstraZeneca CEO Pascal Soriot joins 'Mad Money' host Jim Cramer to talk manufacturing expansion, growth plans, next-gen therapies, and more. Got a confidential news tip? We want to hear from you. Sign ...

Add Yahoo as a preferred source to see more of our stories on Google. U.S. President Donald Trump speaks during an announcement about lowering U.S. drug prices next to Secretary of Commerce Howard ...

AstraZeneca CEO Pascal Soriot on Tuesday reiterated the pharmaceutical firm's commitment to the U.S. market amid reports that he is considering shifting its listing stateside. Soriot said the ...